‘Bombshell’ Study of Pfizer COVID Vaccine Suggests Some People Got Highly Dangerous Shots, Others Got a Placebo
Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches demonstrated higher-than-normal severe adverse events in recipients, prompting the researchers to call for further investigation.
Miss a day, miss a lot. Subscribe to The Defender's Top News of the Day. It's free.
Danish scientists uncovered compelling evidence that a significant percentage of the batches of the Pfizer-BioNTech BNT162b2 COVID-19 vaccine distributed in the EU likely consisted of placebos — and the non-placebo batches demonstrated higher-than-normal severe adverse events in recipients.
The scientists published their study in March, as a letter submitted to the European Journal of Clinical Investigation. BNT162b2 is the vaccine granted Emergency Use Authorization from the U.S. Food and Drug Administration and other authorities.
The study initially did not attract attention, but recent media reports brought it to light.
Journalist Kim Iversen, who on Wednesday reported on the study on “The Kim Iversen Show,” called it an “absolute bombshell of a story.”
Iversen cited as her source an article in The Daily Sceptic, also published Wednesday, by five German scientists who have publicly questioned the safety of the vaccines.
The Danish researchers looked at Pfizer-BioNTech vaccines administered in Denmark between December 2020 and January 2022 and found that batches of the Pfizer-BioNTech COVID-19 vaccine could neatly be divided into three groups.
Two of the three groups demonstrated higher-than-normal percentages of severe adverse events in recipients. However, for the third group of batches, a total of zero adverse events were reported.
The researchers also examined data indicating which batches were inspected and tested by regulators and discovered that almost none of the batches from the third group — associated with no severe adverse events — had been inspected.
According to Iversen, the findings suggest that “many of the batches of the Pfizer vaccine administered to the public — up to 30% — were placebos. And even worse, the evidence points to regulators knowing about it and willingly administering them.”
The study’s authors wrote:
“The observed variation in SAE [severe adverse event] rates and seriousness between BTN162b2 vaccine batches in this nationwide study was contrary to the expected homogenous rate and distribution of SAEs between batches.
“In conclusion, the results suggest the existence of a batch-dependent safety signal for the BNT162b2 vaccine, and more studies are warranted to explore this preliminary observation and its consequences.”
Iversen said these results mean “either they were actively experimenting on the public or they were covering up for the fact that the vaccines came with numerous side effects.”
‘This is how placebos would look’
The German scientists first discussed the results of the Danish study last week on a German online talk show, Punkt.Preradovic, hosted by journalist Milena Preradovic.
According to The Daily Sceptic, they analyzed how “the batches used in Denmark, which are represented by the points in the graph, essentially break down into three groups.”
One set of batches, referred to as the “green batches,” accounting for over 60% of the overall sample demonstrated “a moderate or moderately-high level of adverse events associated with them.”
Specifically, one severe adverse event was reported per approximately 400 doses in this batch — much higher than the rate of severe adverse events reported for the influenza vaccine.
Another set of batches, referred to as the “blue batches,” was “associated with an extraordinarily high level of adverse events” — with a rate of reported severe adverse events of 1 in 10 doses, accounting for nearly 50% of the vaccine-related deaths in the sample.
Some batches within the “blue” group had an even higher rate of severe adverse events: up to 1 in every 6 doses.
However, the “blue batches” were administered the least in Denmark, representing less than 5% of the total number of doses in the sample. This led the scientists to note that “these especially bad batches may perhaps have been quietly pulled from the market by public health authorities.”
The third set of batches, referred to as the “yellow batches,” represented approximately 30% of the total number of doses administered in the sample, but were “associated with literally zero suspected adverse events.”
Gerald Dyker, Ph.D., professor of organic chemistry at Ruhr University in Bochum, Germany, and a member of the team of five German scientists calling attention to the Danish study, suggested that “malicious” observers might conclude “this is how placebos would look.”
“Why would a certain group have absolutely no side effects?” Iversen said. “These scientists said the only time you get that is in the control group. That’s the group that was given the placebo.”
‘The regulators knew’
The Daily Sceptic reported that when the German researchers compared the batch numbers with publicly available data on the vaccine batches, “They made the startling discovery that almost none of the harmless batches, unlike the very-bad and not-so-bad batches, appear to have been subject to any quality-control testing at all.”
“What they uncovered through public information … was that some of them were tested and some of them were not,” Iversen said, noting that every single batch in the “blue” group and almost all batches in the “green” group were tested by regulators and were then “rolled out to the public.”
However, when it came to the “yellow” batches, Iversen said the researchers found that all but one were not tested by the regulator.
Dyker told Preradovic, “This would support the initial suspicion that they are maybe in fact something like placebos,” a point further emphasized by Iversen, who said:
“How could this possibly be? What are the chances that the group that got no side effects whatsoever, that looks like a placebo, that looks like saline solution, what are the chances that none of them would have been tested except one, when all the others were tested in the other groups, practically all of them? The chances are next to nothing.”
“Do you know what that showcases right there? That right there shows the regulators knew. They knew they didn’t need to test the saline solution. It would have been a waste of their time, so they didn’t.
“And they released it to the public, and that was 30% of the doses, and they were placebo and they knew they were placebo. That’s what that looks like.”
Observing that many more doses were given from the “blue” and “green” groups, Iversen suggested several possible reasons for this, including that the researchers believe when regulators saw the high percentage of severe adverse events in those two groups, “they quietly pulled” those batches from the market “without telling anybody.”
In reference to the “blue” group, which demonstrated an extraordinarily high percentage of severe adverse events, Iversen said, “It’s possible that this was a different formulation and they rolled it out there as they were experimenting on people.”
She said it could be that it was “an intentional batch and that they were experimenting on the people, giving them this extra dose of something that had something different in it,” she added, “because it looks like if they were giving people placebos, that they were experimenting on people.”
“The only other thing that’s possible is that they were covering up for the massive number of side effects,” Iversen said, adding that there was an “outrageous number of side effects, and the only way to mitigate it and to keep the public calm [was] to give them a placebo. That way, the overall rate of side effects will be way lower.”
Iversen noted that Denmark has a reporting system for severe adverse events similar to the Vaccine Adverse Event Reporting System (VAERS) in the U.S.
VAERS has historically been shown to report only 1% of actual vaccine adverse events.
She said that in such voluntary reporting systems, most people who experience adverse events never report their injuries. “You have to take that into consideration, because that actually skews the numbers lower than higher.”
Suggesting that “This maybe was going on pretty much everywhere the Pfizer vaccines were being administered,” Iversen called for an investigation to be launched in the U.S.:
“This obviously needs to be investigated, and we would like to see this investigated here in the United States as well.
“Were they doing this and where were they doing this? Did they notify people that they potentially were getting a placebo? … Were the people aware that they were in a clinical trial essentially? That’s what that is. That is a test, you are a test subject … and they were collecting data.
“This is criminal.”
https://childrenshealthdefense.org/defender/pfizer-biontech-covid-vaccine-placebo/
Studi 'Bom' tentang Vaksin COVID Pfizer Menyarankan Beberapa Orang Mendapat Suntikan yang Sangat Berbahaya, Yang Lain Mendapat Plasebo
Ilmuwan Denmark menemukan bukti kuat bahwa persentase yang signifikan dari batch vaksin COVID-19 Pfizer-BioNTech yang didistribusikan di UE kemungkinan terdiri dari plasebo - dan batch non-plasebo menunjukkan efek samping parah yang lebih tinggi dari normal pada penerima, mendorong para peneliti untuk meminta penyelidikan lebih lanjut.
Michael Nevradakis, Ph.D.
Merindukan satu hari, sangat merindukan. Berlangganan Berita Teratas Pembela Hari Ini. Gratis sih.
Ilmuwan Denmark menemukan bukti kuat bahwa persentase yang signifikan dari batch vaksin COVID-19 Pfizer-BioNTech BNT162b2 yang didistribusikan di UE kemungkinan terdiri dari plasebo - dan batch non-plasebo menunjukkan efek samping parah yang lebih tinggi dari normal pada penerima.
Para ilmuwan menerbitkan studi mereka pada bulan Maret, sebagai surat yang diserahkan ke European Journal of Clinical Investigation. BNT162b2 adalah vaksin yang diberikan Otorisasi Penggunaan Darurat dari AS. Administrasi Makanan dan Obat-obatan dan otoritas lainnya.
Studi ini awalnya tidak menarik perhatian, tetapi laporan media baru-baru ini mengungkapnya.
Jurnalis Kim Iversen, yang pada hari Rabu melaporkan studi tentang "Pertunjukan Kim Iversen," menyebutnya sebagai "bom mutlak dari sebuah cerita."
Iversen mengutip sebagai sumbernya sebuah artikel di The Daily Sceptic, juga diterbitkan pada hari Rabu, oleh lima ilmuwan Jerman yang secara terbuka mempertanyakan keamanan vaksin.
Para peneliti Denmark melihat vaksin Pfizer-BioNTech yang diberikan di Denmark antara Desember 2020 dan Januari 2022 dan menemukan bahwa batch vaksin COVID-19 Pfizer-BioNTech dapat dibagi menjadi tiga kelompok dengan rapi.
Dua dari tiga kelompok menunjukkan persentase yang lebih tinggi dari normal dari efek samping yang parah pada penerima. Namun, untuk kelompok batch ketiga, total nol efek samping dilaporkan.
Para peneliti juga memeriksa data yang menunjukkan batch mana yang diperiksa dan diuji oleh regulator dan menemukan bahwa hampir tidak ada batch dari kelompok ketiga - terkait tanpa efek samping yang parah - telah diperiksa.
Menurut Iversen, temuan menunjukkan bahwa "banyak batch vaksin Pfizer yang diberikan kepada publik - hingga 30% - adalah plasebo. Dan lebih buruk lagi, bukti menunjukkan kepada regulator yang mengetahuinya dan dengan sukarela mengelolanya."
Penulis penelitian menulis:
"Variasi yang diamati dalam tingkat dan keseriusan SAE [kejadian buruk parah] antara batch vaksin BTN162b2 dalam studi nasional ini bertentangan dengan tingkat homogen yang diharapkan dan distribusi SAE antar batch.
"Sebagai kesimpulan, hasilnya menunjukkan adanya sinyal keamanan yang bergantung pada batch untuk vaksin BNT162b2, dan lebih banyak penelitian diperlukan untuk mengeksplorasi pengamatan awal ini dan konsekuensinya."
Iversen mengatakan hasil ini berarti "entah mereka secara aktif bereksperimen pada publik atau mereka menutupi fakta bahwa vaksin datang dengan banyak efek samping."
'Beginilah tampilan plasebo'
Para ilmuwan Jerman pertama kali membahas hasil studi Denmark minggu lalu di acara bincang-bincang online Jerman, Punkt.Preradovic, yang dipandu oleh jurnalis Milena Preradovic.
Menurut The Daily Sceptic, mereka menganalisis bagaimana "batch yang digunakan di Denmark, yang diwakili oleh titik-titik dalam grafik, pada dasarnya dipecah menjadi tiga kelompok."
Satu set batch, disebut sebagai "batch hijau," terhitung lebih dari 60% dari keseluruhan sampel menunjukkan "tingkat efek samping sedang atau sedang-tinggi yang terkait dengannya."
Secara khusus, satu efek samping parah dilaporkan per sekitar 400 dosis dalam kelompok ini - jauh lebih tinggi daripada tingkat efek samping parah yang dilaporkan untuk vaksin influenza.
Kumpulan batch lain, disebut sebagai "batch biru," "terkait dengan tingkat efek samping yang luar biasa tinggi" - dengan tingkat efek samping parah yang dilaporkan sebesar 1 dari 10 dosis, terhitung hampir 50% dari kematian terkait vaksin dalam sampel.
Beberapa kelompok dalam kelompok "biru" memiliki tingkat efek samping parah yang lebih tinggi: hingga 1 dalam setiap 6 dosis.
Namun, "batch biru" diberikan paling sedikit di Denmark, mewakili kurang dari 5% dari jumlah total dosis dalam sampel. Hal ini membuat para ilmuwan mencatat bahwa "batch yang sangat buruk ini mungkin diam-diam ditarik dari pasar oleh otoritas kesehatan masyarakat."
Kumpulan batch ketiga, disebut sebagai "batch kuning," mewakili sekitar 30% dari jumlah total dosis yang diberikan dalam sampel, tetapi "terkait dengan nol dugaan efek samping."
Gerald Dyker, Ph.D., profesor kimia organik di Universitas Ruhr di Bochum, Jerman, dan anggota tim yang terdiri dari lima ilmuwan Jerman yang menarik perhatian pada studi Denmark, menyarankan bahwa pengamat "jahat" mungkin menyimpulkan "begitulah tampilan plasebo."
"Mengapa kelompok tertentu sama sekali tidak memiliki efek samping?" Iversen berkata. “Para ilmuwan ini mengatakan satu-satunya waktu yang Anda dapatkan adalah dalam kelompok kontrol. Itulah kelompok yang diberi plasebo.”
'Regulator tahu'
The Daily Sceptic melaporkan bahwa ketika para peneliti Jerman membandingkan nomor batch dengan data yang tersedia untuk umum pada batch vaksin, "Mereka membuat penemuan mengejutkan bahwa hampir tidak ada batch yang tidak berbahaya, tidak seperti batch yang sangat buruk dan tidak terlalu buruk, tampaknya telah tunduk pada pengujian kontrol kualitas sama sekali."
"Apa yang mereka temukan melalui informasi publik ... adalah bahwa beberapa dari mereka diuji dan beberapa dari mereka tidak," kata Iversen, mencatat bahwa setiap kelompok dalam kelompok "biru" dan hampir semua kelompok dalam kelompok "hijau" diuji oleh regulator dan kemudian "digulirkan ke publik."
Namun, ketika datang ke batch "kuning", Iversen mengatakan para peneliti menemukan bahwa semua kecuali satu tidak diuji oleh regulator.
Dyker mengatakan kepada Preradovic, "Ini akan mendukung kecurigaan awal bahwa mereka mungkin sebenarnya seperti plasebo," sebuah poin yang lebih ditekankan oleh Iversen, yang mengatakan:
“Bagaimana ini bisa terjadi? Apa kemungkinan bahwa kelompok yang tidak memiliki efek samping apa pun, yang terlihat seperti plasebo, yang terlihat seperti larutan garam, apa kemungkinan bahwa tidak satu pun dari mereka akan diuji kecuali satu, ketika semua yang lain diuji di kelompok lain, hampir semuanya? Kemungkinannya hampir tidak ada.”
"Apakah kamu tahu apa yang dipamerkan di sana? Itu di sana menunjukkan regulator tahu. Mereka tahu mereka tidak perlu menguji larutan garam. Itu akan membuang-buang waktu mereka, jadi mereka tidak melakukannya.
"Dan mereka merilisnya ke publik, dan itu adalah 30% dari dosis, dan mereka adalah plasebo dan mereka tahu mereka adalah plasebo. Seperti itulah tampilannya.”
Mengamati bahwa lebih banyak dosis diberikan dari kelompok "biru" dan "hijau", Iversen menyarankan beberapa kemungkinan alasan untuk ini, termasuk bahwa para peneliti percaya ketika regulator melihat tingginya persentase efek samping yang parah pada kedua kelompok tersebut, "mereka diam-diam menarik" batch tersebut dari pasar "tanpa memberi tahu siapa pun."
Mengacu pada kelompok "biru", yang menunjukkan persentase efek samping yang sangat tinggi, Iversen berkata, "Ada kemungkinan bahwa ini adalah formulasi yang berbeda dan mereka meluncurkannya di sana saat mereka bereksperimen pada orang-orang."
Dia mengatakan itu bisa jadi bahwa itu adalah "kelompok yang disengaja dan bahwa mereka bereksperimen pada orang-orang, memberi mereka dosis ekstra dari sesuatu yang memiliki sesuatu yang berbeda di dalamnya," dia menambahkan, "karena sepertinya jika mereka memberi orang plasebo, bahwa mereka bereksperimen pada orang-orang."
"Satu-satunya hal lain yang mungkin adalah mereka menutupi sejumlah besar efek samping," kata Iversen, menambahkan bahwa ada "jumlah efek samping yang keterlaluan, dan satu-satunya cara untuk menguranginya dan menjaga ketenangan publik [adalah] memberi mereka plasebo. Dengan begitu, tingkat efek samping secara keseluruhan akan jauh lebih rendah.”
Iversen mencatat bahwa Denmark memiliki sistem pelaporan untuk efek samping parah yang mirip dengan Vaccine Adverse Event Reporting System (VAERS) di AS.
VAERS secara historis telah terbukti melaporkan hanya 1% dari efek samping vaksin yang sebenarnya.
Dia mengatakan bahwa dalam sistem pelaporan sukarela seperti itu, kebanyakan orang yang mengalami efek samping tidak pernah melaporkan cedera mereka. "Anda harus mempertimbangkannya, karena itu benar-benar membelokkan angka yang lebih rendah daripada yang lebih tinggi."
Menyarankan bahwa "Ini mungkin terjadi hampir di mana-mana vaksin Pfizer diberikan," Iversen menyerukan penyelidikan untuk diluncurkan di AS:
“Ini jelas perlu diselidiki, dan kami ingin melihat ini diselidiki di sini di Amerika Serikat juga.
“Apakah mereka melakukan ini dan di mana mereka melakukan ini? Apakah mereka memberi tahu orang-orang bahwa mereka berpotensi mendapatkan plasebo? ... Apakah orang-orang sadar bahwa mereka pada dasarnya berada dalam uji klinis? Itulah yang terjadi. Itu adalah tes, Anda adalah subjek tes ... dan mereka mengumpulkan data.
"Ini kriminal."
Https://childrenshealthdefense.org/defender/pfizer-biontech-covid-vaccine-placebo/
No comments:
Post a Comment